Feiba
Ended Awarded
- Contract number
- 36C26123N0805
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $26,976
Award facts
- Contract value 100% obligated
- $26,975.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $27,000 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule to provide FEIBA from August 18th to September 30th, 2023. As the prime contractor, Takeda will deliver the Factor Eight Inhibitor Bypassing Activity product to support VHA's care of veterans in Veterans Integrated Service Network 21, headquartered in Lexington, Massachusetts. No subcontractors or set aside designations were identified. This order was issued under Takeda's parent company Takeda Pharmaceutical Company Limited's existing pharmaceutical vehicle to streamline procurement of these critical clotting factor treatments for patients in the VA healthcare system.
Quick answers
Who was awarded contract 36C26123N0805?
36C26123N0805 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on August 18, 2023.
How much is contract 36C26123N0805 worth?
The government has obligated $26,976 on 36C26123N0805.
Is contract 36C26123N0805 an order under another contract?
Yes. 36C26123N0805 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26123N0805 competed?
The extent of competition for 36C26123N0805 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award